Novartis Aktie
111,50
EUR
+1,35
EUR
+1,23
%
103,82
CHF
+3,44
CHF
+3,43
%
Werbung
Novartis Aktie Analyse
27.03.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
27.03.19 | Novartis buy | Jefferies & Company Inc. | |
25.03.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
04.03.19 | Novartis Neutral | UBS AG | |
26.02.19 | Novartis Underweight | JP Morgan Chase & Co. | |
06.02.19 | Novartis Hold | HSBC | |
04.02.19 | Novartis Hold | Deutsche Bank AG | |
01.02.19 | Novartis Underweight | Barclays Capital | |
Werbung
|
|||
01.02.19 | Novartis Underweight | JP Morgan Chase & Co. | |
31.01.19 | Novartis Neutral | Credit Suisse Group | |
31.01.19 | Novartis Underweight | JP Morgan Chase & Co. | |
31.01.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
30.01.19 | Novartis Hold | Deutsche Bank AG | |
30.01.19 | Novartis Neutral | UBS AG | |
30.01.19 | Novartis buy | Kepler Cheuvreux | |
30.01.19 | Novartis buy | Jefferies & Company Inc. | |
29.01.19 | Novartis Underweight | JP Morgan Chase & Co. | |
24.01.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
18.01.19 | Novartis Neutral | UBS AG | |
16.01.19 | Novartis Underweight | Barclays Capital | |
16.01.19 | Novartis Underweight | JP Morgan Chase & Co. | |
11.01.19 | Novartis Hold | Deutsche Bank AG | |
08.01.19 | Novartis Underweight | JP Morgan Chase & Co. | |
02.01.19 | Novartis Underweight | JP Morgan Chase & Co. | |
14.12.18 | Novartis Equal-Weight | Morgan Stanley | |
14.12.18 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
14.12.18 | Novartis buy | Merrill Lynch & Co., Inc. | |
13.12.18 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
11.12.18 | Novartis buy | Jefferies & Company Inc. | |
10.12.18 | Novartis Hold | Deutsche Bank AG | |
10.12.18 | Novartis buy | Kepler Cheuvreux | |
10.12.18 | Novartis Underweight | Barclays Capital | |
07.12.18 | Novartis Underweight | Barclays Capital | |
28.11.18 | Novartis Neutral | JP Morgan Chase & Co. | |
28.11.18 | Novartis Hold | HSBC | |
21.11.18 | Novartis Neutral | UBS AG | |
19.11.18 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
06.11.18 | Novartis Neutral | JP Morgan Chase & Co. | |
25.10.18 | Novartis Hold | HSBC | |
22.10.18 | Novartis Neutral | JP Morgan Chase & Co. | |
22.10.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
22.10.18 | Novartis Hold | Deutsche Bank AG | |
19.10.18 | Novartis Hold | Baader Bank | |
19.10.18 | Novartis Neutral | Credit Suisse Group | |
18.10.18 | Novartis buy | CFRA | |
18.10.18 | Novartis buy | Jefferies & Company Inc. | |
18.10.18 | Novartis Neutral | JP Morgan Chase & Co. | |
18.10.18 | Novartis buy | Baader Bank | |
16.10.18 | Novartis Neutral | JP Morgan Chase & Co. | |
12.10.18 | Novartis buy | Baader Bank |
Werbung
Werbung